Upon its administration to GCSCs and CD44+ cells sorted from human gastric adenocarcinoma cell line (AGSs), a significant decrease in the proportion of CD44+ cells, in the ability of mammosphere and colony formation, and in the growth of GCSC mammosphere were observed. This evidence concerns the gene CD44 and gastric adenocarcinoma.